MDxHealth (MDXH) Receivables (2020 - 2026)

MDxHealth has disclosed Receivables across 7 years of filings, most recently posting $14.3 million for Q1 2026.

• Receivables for Q1 2026 came in at $14.3 million, down 8.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.3 million (down 8.24% YoY), and the FY2025 annual result was $14.7 million, up 1.63% from the prior year.
• Receivables came in at $14.3 million for Q1 2026 at MDxHealth, down from $14.7 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $18.7 million in Q4 2022 to a low of $788334.0 in Q2 2025.
• The 5-year median for Receivables is $13.1 million (2024), against an average of $11.8 million.
• Across the five-year window, Receivables surged 104.21% in 2022 and slumped 94.14% in 2025, its largest moves.
• MDxHealth's Receivables stood at $18.7 million in 2022, then sank by 40.56% to $11.1 million in 2023, then climbed by 29.81% to $14.4 million in 2024, then grew by 1.63% to $14.7 million in 2025, then retreated by 2.82% to $14.3 million in 2026.
• The last three Receivables figures came in at $14.3 million (Q1 2026), $14.7 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.